Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| Weiss Ratings | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.21 | |||
| Price History | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -63.59% | |||
| 3-Year Total Return | -97.06% | |||
| 5-Year Total Return | -99.70% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.75 | |||
| 52-Week Low Price | $0.75 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Mar 11, 2025 | |||
| Valuation | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 931.99K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -13.29 | |||
| Earnings Per Share Growth | -43.95% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.38 | |||
| Price/Book (Q) | 0.22 | |||
| Enterprise Value/Revenue (TTM) | 14.20 | |||
| Price | $0.75 | |||
| Enterprise Value/EBITDA (TTM) | -0.35 | |||
| Enterprise Value/EBIT | -0.32 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 917 388 1578 | |||
| Address | 6700 Professional Parkway Sarasota, FL 34240 | |||
| Website | www.brainscientific.com | |||
| Country | United States | |||
| Year Founded | 2013 | |||
| Profitability | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,477.35% | |||
| Profit Margin | -5,752.05% | |||
| Management Effectiveness | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -47.81% | |||
| Return on Equity | -- | |||
| Income Statement | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 214.60K | |||
| Total Revenue (TTM) | 214.60K | |||
| Revenue Per Share | $0.17 | |||
| Gross Profit (TTM) | 54.30K | |||
| EBITDA (TTM) | -8.78M | |||
| EBIT (TTM) | -9.61M | |||
| Net Income (TTM) | -12.34M | |||
| Net Income Avl. to Common (TTM) | -12.34M | |||
| Total Revenue Growth (Q YOY) | -97.97% | |||
| Earnings Growth (Q YOY) | 41.48% | |||
| EPS Diluted (TTM) | -13.29 | |||
| EPS Diluted Growth (Q YOY) | 80.76% | |||
| Balance Sheet | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 747.70K | |||
| Cash Per Share (Q) | $0.60 | |||
| Total Current Assets (Q) | 1.31M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.32M | |||
| Current Ratio (Q) | 0.176 | |||
| Book Value Per Share (Q) | $3.47 | |||
| Total Assets (Q) | 11.74M | |||
| Total Current Liabilities (Q) | 7.42M | |||
| Total Debt (Q) | 2.86M | |||
| Total Liabilities (Q) | 7.43M | |||
| Total Common Equity (Q) | 4.32M | |||
| Cash Flow | BRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -33.30K | |||
| Cash from Financing (TTM) | 5.93M | |||
| Net Change in Cash (TTM) | -37.60K | |||
| Levered Free Cash Flow (TTM) | -208.40K | |||
| Cash from Operations (TTM) | -5.94M | |||
